Condensed Consolidated Statements of Shareholders' Equity (Deficit) (Unaudited) - USD ($) $ in Thousands	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Balance at Dec. 31, 2023	$ 11	$ 4,123	$ (6,212)	$ (2,078)
Balance, shares at Dec. 31, 2023	10,562,640
Net loss			(576)	(576)
Balance at Jun. 30, 2024	$ 11	4,123	(6,788)	(2,654)
Balance, shares at Jun. 30, 2024	10,562,640
Balance at Dec. 31, 2023	$ 11	4,123	(6,212)	(2,078)
Balance, shares at Dec. 31, 2023	10,562,640
Balance at Dec. 31, 2024	$ 14	13,577	(8,815)	4,776
Balance, shares at Dec. 31, 2024	13,736,597
Balance at Mar. 31, 2024	$ 11	4,123	(6,535)	(2,401)
Balance, shares at Mar. 31, 2024	10,562,640
Net loss			(253)	(253)
Balance at Jun. 30, 2024	$ 11	4,123	(6,788)	(2,654)
Balance, shares at Jun. 30, 2024	10,562,640
Balance at Dec. 31, 2024	$ 14	13,577	(8,815)	4,776
Balance, shares at Dec. 31, 2024	13,736,597
Common shares issued for cash through equity line of credit, net of expenses	$ 1	209		210
Common shares issued for cash through equity line of credit, net of expenses, shares	510,000
Issuance of common shares recorded as a vendor advance		156		156
Issuance of common shares recorded as a vendor advance, shares	534,188
Fair value of vested restricted stock units		153		153
Fair value of vested restricted stock units, shares	78,521
Net loss			(2,684)	(2,684)
Fair value of common shares issued for deferred offering costs	$ 1	327		328
Fair value of common shares issued for deferred offering costs, shares	384,459
Proceeds from the sale of common shares and pre-funded warrants, net of offering costs	$ 2	3,056		3,058
Proceeds from the sale of common shares and pre-funded warrants, net of offering costs, shares	2,500,000
Balance at Jun. 30, 2025	$ 18	17,478	(11,499)	5,997
Balance, shares at Jun. 30, 2025	17,743,765
Balance at Mar. 31, 2025	$ 17	17,192	(10,077)	7,132
Balance, shares at Mar. 31, 2025	16,376,118
Issuance of common shares upon the exercise of pre-funded warrants
Issuance of common shares upon the exercise of pre-funded warrants, shares	490,000
Common shares issued for cash through equity line of credit, net of expenses	$ 1	209		210
Common shares issued for cash through equity line of credit, net of expenses, shares	510,000
Issuance of common shares recorded as a vendor advance
Issuance of common shares recorded as a vendor advance, shares	367,647
Fair value of vested restricted stock units		77		77
Fair value of vested restricted stock units, shares
Net loss			(1,422)	(1,422)
Balance at Jun. 30, 2025	$ 18	$ 17,478	$ (11,499)	$ 5,997
Balance, shares at Jun. 30, 2025	17,743,765